We have released the 2nd issue of Volume 13! On the cover: "Beyond bNAbs: Uses, Risks, and Opportunities for Therapeutic Application of Non-Neutralising Antibodies in Viral Infection" by Kahlio Mader and Prof. Lynn B. Dustin from Kennedy Institute of Rheumatology Read the whole issue: https://lnkd.in/dv4hkanp
Antibodies MDPI
Book and Periodical Publishing
Antibodies (ISSN 2073-4468), an Open Access journal of antibodies and antigens published online by MDPI.
About us
Antibodies (ISSN 2073-4468, IF 3.0) is an international, peer-reviewed open access journal that provides an advanced forum for scientific publications related to antibodies and antigens. It publishes reviews, research articles, communications and short notes.
- Website
-
https://www.mdpi.com/journal/antibodies
External link for Antibodies MDPI
- Industry
- Book and Periodical Publishing
- Company size
- 11-50 employees
- Headquarters
- Basel
- Type
- Privately Held
Locations
-
Primary
Sankt-Alban Anlage 66
Basel, 4052, CH
Updates
-
Study by Dr. Jihong Wang et al. presents a novel degradation pathway of a human immunoglobulin G (IgG) molecule featuring a light chain N-terminal asparagine: https://lnkd.in/d4nZdpEx
-
Dr. Vikrant Rai and colleagues at Western University of Health Sciences discuss the etiology of various forms of breast cancer and current treatment modalities followed by the significance of neoantigens in cancer therapeutics and their application to breast cancer: https://lnkd.in/d2bXzmFH
Targeting Neoantigens in Cancer: Possibilities and Opportunities in Breast Cancer
mdpi.com
-
We will be attending the 31st International Carbohydrate Symposium (ICS2024), which will be held from 14 to 19 July 2024 in Shanghai, China. If you are planning to attend the conference, we encourage you to visit our booth B3. https://lnkd.in/dJphRQBB
-
-
Review by Dr. Alshamrani provides an overview of approved immunotherapeutic strategies for Alzheimer’s disease and those currently being investigated in clinical trials: https://lnkd.in/dNGr5Vpi
Recent Trends in Active and Passive Immunotherapies of Alzheimer’s Disease
mdpi.com
-
The Antibodies Travel Award is presented every year to encourage junior scientists to present their latest research at academic conferences in the field of antibodies and antigens. The application deadline is 31st October 2024. Find out more at: https://lnkd.in/drWv_why
-
-
Review by Prof. Dr. Marino Paroli and Dr. Maria Isabella Sirinian from Sapienza Università di Roma aims to summarize the data provided in the scientific literature with the goal of helping clinicians diagnose seronegative rheumatoid arthritis (SNRA) as accurately as possible: https://lnkd.in/d3XKDYsg
When Autoantibodies Are Missing: The Challenge of Seronegative Rheumatoid Arthritis
mdpi.com
-
Dr. Robert Pejchal et al. produced a large panel of representative mutations previously described in the literature and in many cases in clinical or approved molecules, generated select combinations thereof, and characterized their binding and biophysical properties: https://lnkd.in/dgA6TTPb
Profiling the Biophysical Developability Properties of Common IgG1 Fc Effector Silencing Variants
mdpi.com
-
Dr. Qiang Yang, Prof. Lai-Xi Wang et al. conducted a systemic evaluation of two endoglycosidase-catalyzed chemoenzymatic glycoengineering technologies to prepare glycosite-specific antibody–drug conjugates: https://lnkd.in/gGeHerHY
Evaluation of Two Chemoenzymatic Glycan Remodeling Approaches to Generate Site-Specific Antibody–Drug Conjugates
mdpi.com
-
Empirical data suggests a correlation between celiac disease and reproductive abnormalities. Dr. Metodija Sekulovsketi al. conducted a review of the literature on this topic and tried to elucidate the role of the autoantibodies in its pathogenesis: https://lnkd.in/dPH_Yis9
Navigating the Challenges of Gluten Enteropathy and Infertility: The Role of Celiac-Related Antibodies and Dietary Changes
mdpi.com